The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,050.00
Bid: 4,010.00
Ask: 4,040.00
Change: -20.00 (-0.49%)
Spread: 30.00 (0.748%)
Open: 3,980.00
High: 4,050.00
Low: 3,980.00
Prev. Close: 4,070.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

8 Sep 2011 13:45

RNS Number : 8996N
North Atlantic Smlr Co Inv Tst PLC
08 September 2011
 



North Atlantic Smaller Companies Investment Trust PLC

Half-Yearly Financial Report for the six months ended 31 July 2011

 

The Directors of North Atlantic Smaller Companies Investment Trust plc report the unaudited results of the Company for the six months ended 31 July 2011.

 

 

31 July

2011

(unaudited)

31 January

2011

(audited)

%

Change

Net asset value per 5p Ordinary Share*:

Basic

1,614p 

1,664p 

(3.0)

Diluted

1,433p 

1,459p 

(1.8)

Mid-market price of the 5p Ordinary Shares

1,059.5p 

1,146.0p 

(7.5)

Discount to diluted net asset value*

26.1%

21.5%

Standard & Poor's 500 Composite Index**

786.7

803.1

(2.0)

Russell 2000 Index **

485.2

487.9

(0.6)

FTSE All-Share Index

3,026.0

3,044.3

(0.6)

US Dollar/Sterling exchange rate

1.6415

1.6018

2.5

 

* Including retained revenue for the period.

** Sterling adjusted.

 

CHIEF EXECUTIVE'S REVIEW

During the period under review, the diluted net asset value of the Company fell by 1.8%. This compares with a fall in the Standard & Poors Composite Index (Sterling adjusted) of 2.0%.

The revenue return after tax for the period to 31 July 2011 amounted to a loss of £1,161,000 (31 July 2010: profit of £1,880,000). Consistent with past policy, the directors do not propose to pay a dividend.

quoted portfolio

The quoted portfolio taken as a whole outperformed the index, principally due to excellent results from RPC which rose 30% during the period under review. Set against this, the price performance of BBA -5% and Gleeson -15% was disappointing, although the underlying performance of both of these businesses has been encouraging. The United States portfolio, albeit relatively small, also performed better than the indices.

unquoted portfolio

The principal problem during the period under review was the need to write down the holding in Assetco by 50%. The remainder of the portfolio has generally performed well but in light of uncertain market conditions, the Board feels it would be inappropriate to increase valuations at this time. The holding in Lion/Katsu has now been sold for cash in excess of the valuation as at 31 January 2011. Also, with regard to the investment in Izodia, the Company has received a liquidation payment equal to the holding cost of the investment and expects to receive a further small payment in due course. No new investments were made during the period.

outlook

Since the end of the period there has been a substantial fall in world equity markets, although the impact on the portfolio has been less than that of the overall indices. However, the nature of the Company's portfolio is such that there are catalysts that should create value, regardless of market conditions over the medium term. I am therefore hopeful that the current turmoil in markets will create opportunities which will enable the Company to prosper in the long term.

C H B Mills

Chief Executive

8 September 2011

TOP TEN INVESTMENTS

as at 31 July 2011

Company

Fair

value

£'000

% of

net assets

Bionostics Holdings Limited

UK Unquoted

20,882

9.2

Oryx International Growth Fund Limited*†

UK Listed

20,750

9.1

RPC Group PLC

UK Listed

17,840

7.8

Guinness Peat Group PLC

NZ Listed

15,331

6.7

Hampton Investment Properties Limited

UK Unquoted

14,118

6.2

Trident Private Equity Fund III LP

UK Unquoted

12,309

5.4

BBA Aviation Group PLC

UK Listed

11,627

5.1

Nationwide Accident Repair Services PLC

UK Quoted on AIM

9,200

4.0

Interxion Holdings NV

USA Listed

9,041

4.0

MJ Gleeson Group PLC

UK Listed

7,477

3.3

138,575

60.8

* Incorporated in Guernsey

Oryx is accounted for in the Group accounts as an Associate under the equity method of accounting. The valuation shown above is the Group's share of Oryx's net assets. All other investments are valued at fair value.

 

INTERIM MANAGEMENT REPORT

investment objective

The objective of North Atlantic Smaller Companies Investment Trust plc ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

material events

On 14 July 2011, Mr C H B Mills was granted 420,000 options to acquire Ordinary Shares pursuant to the 2011 Share Option Scheme at a price per option of 1467.71 pence exercisable between 14 July 2014 and 14 July 2021 providing that the necessary performance requirements have been met. The 2011 Share Option Scheme was approved by Shareholders at the Annual General Meeting of the Company held on 30 June 2011. Further details of the Scheme can be found in the Appendix to the Notice of Annual General Meeting on pages 86 to 88 of the Annual Report for the year ended 31 January 2011.

material transactions

The Board do not consider that there were any material transactions during the period ended 31 July 2011.

risk profile

The principal risks and uncertainties for the remaining six months of the year continue to be as described in the Annual Report for the year ended 31 January 2011 on pages 68 to 77. The principal risks arising from the Company's financial instruments are market price risk and foreign currency risk. The Directors review and agree policies with the Joint Manager, North Atlantic Value LLP, for managing these risks. The policies have remained substantially unchanged in the six months since the year end.

The Group does not have any significant exposure to credit risk arising from any one individual party. Credit risk is spread across a number of companies, each having an immaterial effect on the Group's cash flows, should a default occur.

To support its investment in unquoted companies, the Group may periodically agree to guarantee all or part of the borrowings of investee companies. Provision is made for any costs that may be incurred when the Directors consider it likely that the guarantee will crystallise.

The Group's exposure to market price risk comprises mainly movements in the value of the Group's investments. It should be noted that the prices of options tend to be more volatile than the prices of the underlying securities.

 

The functional and presentational currency of the Group is Sterling, and therefore, the Group's principal exposure to foreign currency risk comprises investments priced in other currencies, principally US Dollars.

The Group invests in equities and other investments that are normally readily realisable.

related party transactions

These are listed in note 10 to the half yearly condensed financial statements below.

CULS

The Convertible Unsecured Loan Stock ('CULS') were issued in units of 5p each. The units are redeemable at par on 31 May 2013, unless previously redeemed, purchased by the Company, or converted at the option of the holder. Interest is payable to holders of the CULS at a rate of 0.5p gross per 5p unit per annum on 31 January each year.

The CULS units are convertible into Ordinary Shares of 5p each at a rate of one Ordinary Share for every 5p unit, one month after dispatch of the audited accounts in each of the years 2011 to 2013 inclusive.

During the six months ended 31 July 2011, 171,301 (2010: 507,025) units of CULS were converted into Ordinary Shares of 5p each at the rate of one 5p Ordinary Share for every unit of 5p. The Company did not purchase any units of CULS for cancellation during the period under review (2010: 1,085,000 units were purchased by the Company for cancellation).

As at 31 July 2011, there were 1,799,499 units of CULS outstanding.

C H B Mills

Chief Executive

8 September 2011

 

RESPONSIBILITY STATEMENT

The Directors confirm to the best of their knowledge that:

·; The condensed set of financial statements contained within this half yearly financial report have been prepared in accordance with International Accounting Standard 34 'Interim Financial Reporting' as adopted by the European Union and gives a true and fair view of the assets, liabilities, financial position and loss of the Group; and

·; The half yearly financial report includes a fair review of the information required by the FSA's Disclosure and Transparency Rule 4.2.7R being disclosure of important events that have occurred during the first six months of the financial year, their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the year; and

·; The half yearly financial report includes a fair review of the information required by the FSA's Disclosure and Transparency Rule 4.2.8R being disclosure of related party transactions during the first six months of the financial year, how they have materially affected the financial position of the Group during the period and any changes therein.

The half yearly financial report was approved by the Board on 8 September 2011 and the above responsibility statement was signed on its behalf by:

The Hon. P D E M Moncreiffe

Chairman

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

Six months ended

31 July

2011

(unaudited)

Six months ended

31 July

2010

(unaudited)

Year ended

31 January

2011

(audited)

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Investment income

779 

-

779 

874 

-

874 

2,341 

2,341 

Net (losses)/gains on investments at fair value through profit or loss

(3,029)

(3,029)

20,568 

20,568 

37,868 

37,868 

Currency exchange (losses)/gains

(782)

(782)

559 

559 

(19)

(19)

total income

779 

(3,811)

(3,032)

874 

21,127 

22,001 

2,341 

37,849 

40,190 

Expenses

Investment management fee (note 2)

(1,199)

(163)

(1,362)

(1,127)

(500)

(1,627)

(2,255)

(1,219)

(3,474)

Share based remuneration

2,544 

2,544 

Other expenses

(674)

(674)

(320)

(320)

(728)

(728)

Share of net return of associate

426 

426 

1,350 

1,350 

4,619 

4,619 

return before finance costs and taxation

(1,094)

(3,548)

(4,642)

1,971 

21,977 

23,948 

(642)

41,249 

40,607 

Finance costs

(67)

(67)

(91)

(91)

(207)

(207)

return before taxation

(1,161)

(3,548)

(4,709)

1,880 

21,977 

23,857 

(849)

41,249 

40,400 

Taxation

-

return for the period

(1,161)

(3,548)

(4,709)

1,880 

21,977 

23,857 

(849)

41,249 

40,400 

other comprehensive income

total comprehensive (loss) /income for the period

(1,161)

(3,548)

(4,709)

1,880 

21,977 

23,857 

(849)

41,249 

40,400 

earnings per ordinary share (note 4)

Basic

(33.61p)

161.49p

278.84p

Diluted

(29.46p)

132.92p

236.80p

 

All of the total comprehensive (loss)/income for the period is attributable to the owners of the Group.

The total column of the statement is the Statement of Comprehensive Income of the Group prepared in accordance with IFRS. The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice issued by the Association of Investment Companies.

All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the period.

 

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

Share

capital

£'000

Capital

redemption

reserve

£'000

CULS

reserve

£'000

Share

options

reserve

£'000

Share

premium

account

£'000

Capital

reserve

£'000

Revenue

reserve

£'000

Total

£'000

six months ended 31 July 2011 (unaudited)

31 January 2011

703 

69

15 

229 

1,301

234,377 

(2,798)

233,896 

Total comprehensive income for the period

-

-

(3,548)

(1,161)

(4,709)

Shares purchased for cancellation

(6)

6

-

(1,266)

(1,266)

Arising on conversion of CULS

-

(2)

-

Transfer between reserves

-

4,447 

-

(4,447)

Settlement of outstanding share options

-

(120)

-

(120)

31 July 2011

706 

75

13 

4,556 

1,301

225,116 

(3,959)

227,808 

six months ended 31 July 2010 (unaudited)

31 January 2010

741 

-

27 

1,348 

629

218,665 

(1,949)

219,461 

Total comprehensive income for the period

-

-

21,977 

1,880 

23,857 

New issue of ordinary shares

-

673

678 

Shares purchased for cancellation

(57)

57

-

(10,667)

(10,667)

Premium paid on repurchase of CULSfor cancellation

-

(8)

-

(9,496)

(9,504)

Arising on conversion of CULS

26 

-

(4)

-

22 

Exercise of management options

-

(5,891)

-

(5,891)

Share options expense

-

(504)

-

(504)

31 July 2010

715 

57

15 

(5,047)

1,302

220,479 

(69)

217,452 

year ended 31 January 2011 (audited)

31 January 2010

741 

-

27 

1,348 

629

218,665 

(1,949)

219,461 

Total comprehensive income for the year

-

-

41,249 

(849)

40,400 

New issue of ordinary shares

-

672

677 

Shares purchased for cancellation

(69)

69

-

(13,029)

(13,029)

Premium paid on repurchase of CULSfor cancellation

-

(8)

-

(9,740)

(9,748)

Arising on conversion of CULS

26 

-

(4)

-

22 

Settlement of outstanding share options

-

-

(3,887)

(3,887)

Transfer between reserves

-

(1,119)

-

1,119 

31 January 2011

703 

69

15 

229 

1,301

234,377 

(2,798)

233,896 

 

CONDENSED CONSOLIDATED BALANCE SHEET

 

31 July

2011

(unaudited)

£'000

31 July

2010

(unaudited)

£'000

31 January

2011

(audited)

£'000

non current assets

Investments at fair value through profit or loss

190,231 

164,951 

187,447 

Investments accounted for using the equity method

20,750 

17,055 

20,324 

210,981 

182,006 

207,771 

current assets

Investments held by Subsidiary Companies for trading

404 

367 

550 

Trade and other receivables

1,327 

15,266 

2,818 

Cash and cash equivalents

15,425 

26,421 

30,343 

17,156 

42,054 

33,711 

total assets

228,137 

224,060 

241,482 

current liabilities

Bank loans and overdrafts

(5,624)

(5,786)

Trade and other payables

(253)

(899)

(1,716)

(253)

(6,523)

(7,502)

total assets less current liabilities

227,884 

217,537 

233,980 

non current liabilities

CULS

(76)

(85)

(84)

(76)

(85)

(84)

total liabilities

(329)

(6,608)

(7,586)

net assets

227,808 

217,452 

233,896 

represented by:

Share capital

706 

715 

703 

Capital redemption reserve

75 

57 

69 

Equity component of CULS

13 

15 

15 

Share options reserve

4,556 

(5,047)

229 

Share premium account

1,301 

1,302 

1,301 

Capital reserve

225,116 

220,479 

234,377 

Revenue reserve

(3,959)

(69)

(2,798)

equity attributable to equity holders of the parent

227,808 

217,452 

233,896 

net asset value per ordinary share (note 5):

Basic

1,614p

1,521p

1,664p

Diluted

1,433p

1,335p

1,459p

 

CONDENSED CONSOLIDATED CASH FLOW STATEMENT

 

Note

Six months

ended 31 July

2011

(unaudited)

£'000

Six months

ended 31 July

2010

(unaudited)

£'000

Year ended

31 July

2011

(audited)

£'000

cash flows from operating activities

Investment income received

709 

895 

1,788 

Bank deposit interest received

18 

24 

58 

Other income

524 

202 

339 

Sale of investments by dealing subsidiary

58 

Investment Manager's fees paid

(2,446)

(2,299)

(3,476)

Other cash receipts/(payments)

364 

(4,195)

(5,742)

cash expended from operations

9

(773)

(5,373)

(7,033)

Bank interest paid

(73)

(87)

(179)

CULS interest paid

(10)

Loan revenue expenses

(9)

net cash outflow from operating activities

(846)

(5,460)

(7,231)

cash flows from investing activities

Purchases of investments

(70,879)

(37,885)

(109,056)

Sales of investments

64,293 

58,811 

138,648 

net cash (outflow)/inflow from investing activities

(6,586)

20,926 

29,592 

cash flows from financing activities

Repayment of fixed term borrowings

(5,960)

New issue of ordinary shares

678 

677 

Shares purchased for cancellation

(1,266)

(10,667)

(13,029)

Repurchase of CULS for cancellation

(9,551)

(9,795)

net cash outflow from financing activities

(7,226)

(19,540)

(22,147)

(decrease)/increase in cash and cash equivalents for the period

(14,658)

(4,074)

214 

cash and cash equivalents at the start of the period

30,343 

29,600 

29,600 

Revaluation of foreign currency balances

(260)

895 

529 

cash and cash equivalents at the end of the period

15,425 

26,421 

30,343 

 

NOTES

 

1. general information and basis of preparation

North Atlantic Smaller Companies Investment Trust plc ("NASCIT") is a Company incorporated and registered in England and Wales under the Companies Acts 1948 to 1967.

 

The Company operates as an investment trust company within the meaning of Section 833 of the Companies Act 2006 and is managed in such a way to ensure the Company meets the requirements of Sections 1158 and 1159 of the Corporation Tax Act 2010 for which the Company seeks annual approval from HM Revenue and Customs.

The condensed consolidated interim financial statements for the six months ended 31 July 2011 have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all financial information required for full annual financial statements and have been prepared using the accounting policies adopted in the audited financial statements for the year ended 31 January 2011. Those financial statements were prepared in accordance with International Financial Reporting Standards except as disclosed in note 2 of that report, and with the Statement of Recommended Practice ('SORP') for Investment Companies and Venture Capital Trusts issued by the Association of Investment Companies in January 2009.

The condensed consolidated interim financial information consolidate the financial statements of the Company and its wholly owned Subsidiary, Consolidated Venture Finance Limited, for the six months ended 31 July 2011.

The Company has adequate financial resources and no significant investment commitments and as a consequence, the Directors believe that the Company is well placed to manage its business risks successfully. After making appropriate enquiries, the Directors have a reasonable expectation that the Company has adequate available financial resources to continue in operational existence for the foreseeable future and accordingly have concluded that it is appropriate to continue to adopt the going concern basis in preparing this half yearly financial report.

 

2. investment management and performance fees

A Performance Fee is only payable if the investment portfolio outperforms the Sterling adjusted Standard & Poor's 500 Composite Index at the end of each financial year and is limited to a maximum payment of 0.5% of Shareholders' Funds.

In accordance with the Statement of Recommended Practice ("SORP") for investment trust companies, an amount is included in these financial statements for the Performance Fee that could be payable based on investment performance to 31 July 2011.

At that date, a Performance Fee of £163,000 including irrecoverable VAT has been accrued for in the accounts (31 July 2010: £500,000; 31 January 2011: £1,219,000) and is allocated 100% to capital. The performance fee of £163,000 includes a £155,000 adjustment to irrecoverable VAT on the performance fee for the year to January 2011, due to a change in the recoverable VAT rate of the Company.

3. taxation

The Company has an effective tax rate of 0%. The estimated effective tax rate is 0% as investment gains are exempt from tax owing to the Company's status as an Investment Trust and there is expected to be an excess of management expenses over taxable income and thus there is no charge for corporation tax.

4. earnings per ordinary share

 

Revenue

Capital

Total

*Net

return

£'000

Ordinary

Shares

Per

Share

pence

*Net

return

£'000

Ordinary

Shares

Per

Share

pence

*Net

return

£'000

Ordinary

Shares

Per

Share

pence

six months ended 31 July 2011 (unaudited)

Basic return per Share

(1,161)

14,011,093

(8.29)

(3,548)

14,011,093

(25.32)

(4,709)

14,011,093

(33.61)

CULS**

10 

1,941,461

-

1,941,461

10 

1,941,461

Diluted return per Share

(1,151)

15,952,554

(7.22)

(3,548)

15,952,554

(22.24)

(4,699)

15,952,554

(29.46)

six months ended 31 July 2010 (unaudited)

Basic return per Share

1,880 

14,772,954

12.72 

21,977 

14,772,954

148.77 

23,857 

14,772,954

161.49 

CULS**

16 

3,186,922

3,186,922

16 

3,186,922

Diluted return per Share

1,896 

17,959,876

10.55 

21,977 

17,959,876

122.37 

23,873 

17,959,876

132.92 

year ended 31 January 2011 (audited)

Basic return per Share

(849)

14,488,339

(5.86)

41,249 

14,488,339

284.70 

40,400 

14,488,339

278.84 

CULS**

13 

2,577,905

2,577,905

13 

2,577,905

Diluted return per Share

(836)

17,066,244

(4.90)

41,249 

17,066,244

241.70 

40,413 

17,066,244

236.80 

 

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

* Net return on ordinary activities attributable to Ordinary Shareholders.

** CULS interest cost and excess of the total number of potential shares on CULS conversion over the number that could be issued at the average market price from the conversion proceeds, as calculated in accordance with IAS 33: Earnings per share.

5. net asset value per ordinary share

The basic net asset value per Ordinary Share is based on net assets of £227,808,000 (31 July 2010: £217,452,000; 31 January 2011: £233,896,000) and on 14,113,553 Ordinary Shares (31 July 2010: 14,292,252; 31 January 2011: 14,057,252) being the number of Ordinary Shares in issue at the period end.

The diluted net asset value per Ordinary Share is calculated on the assumption that the outstanding 2013 CULS are fully converted at par and that all 430,000 (31 July 2010: 20,000; 31 January 2011: 20,000) Share Options in-the-money were exercised at the prevailing exercise prices, giving a total of 16,343,052 issued Ordinary Shares (31 July 2010: 16,308,052; 31 January 2011: 16,048,052).

There were 3 buybacks of Ordinary 5p shares for cancellation during the period:

On 25 March 2011, 10,000 bought back at a cost of £109,000.

On 1 April 2011, 25,000 bought back at a cost of £275,000.

On 5 April 2011, 80,000 bought back at a cost of £882,000.

6. debenture loan - convertible unsecured loan stock ('CULS') 2013

On 30 June 2011 171,301 CULS units were converted into 171,301 Ordinary shares of 5p each at a rate of one 5p Ordinary share for every unit of 5p.

At 31 July 2011, 1,799,499 CULS units remained outstanding.

7. share based remuneration

On 14 July 2011 C H B Mills (Mr Mills) was granted 420,000 share options under the NASCIT 2011 Executive Share Option Scheme at an exercise price of 1,467.71p per share. A further 10,000 options were granted to other employees. These are exercisable providing the necessary performance requirements are met between 14 July 2014 and 14 July 2021.

Further to a review of the NASCIT 2002 Executive Share Option Scheme, all of the remaining option holders waived their rights to future participation. As part of the review of the incentive scheme, it was agreed that, subject to the proceeds being reinvested in NASCIT shares and those shares being held for a period of not less than two years, an ex gratia payment totalling £120,000 be paid to those eligible employees of North Atlantic Value LLP.

8. bank loans

The Company's multi-currency loan Revolving Credit Facility of up to £9 million expired on 29 July 2011.

During the period the Company made two repayments in order to fully repay the €6.8 million loan by 29 July 2011.

9. reconciliation of total return from ordinary activities before finance costs and taxation to cash expendedfrom operations

 

Six months

ended 31 July

2011

(unaudited)

£'000

Six months

ended 31 July

2010

(unaudited)

£'000

Year ended

31 July

2011

(audited)

£'000

Return before finance costs and taxation*

(4,642)

23,948 

40,607 

Losses/(gains) on investments

3,811 

(21,127)

(37,849)

Settlement of outstanding share options

(120)

(3,851)

(3,887)

Share based remuneration

(2,544)

Share of net return of associate

(426)

(1,350)

(4,619)

Dividends and interest reinvested

(588)

(649)

Decrease/(increase) in debtors and accrued income

1,470 

59 

(1,324)

Changes relating to investments of dealing Subsidiaries

569 

710 

530 

(Decrease)/increase in creditors and accruals

(1,435)

(630)

158 

cash expended from operations

(773)

(5,373)

(7,033)

 

* Including share of net return of associate.

 

10. related party transactions

There have been no changes to the related party arrangements or transactions as reported in the Statutory Annual Financial Report for the year ended 31 January 2011.

The Joint Manager, North Atlantic Value LLP, is regarded as a related party of the Company. The amounts payable to the Joint Manager and Growth Financial Services Limited ("GFS") in respect of investment management for the six months to 31 July 2011 are as follows:

Six months

ended 31 July

2011

(unaudited)

£'000

Six months

ended 31 July

2010

(unaudited)

£'000

Year ended

31 July

2011

(audited)

£'000

Annual fee

1,199

1,127

2,255

Performance fee

7

538

1,176

Irrecoverable VAT thereon

1

28

36

Irrecoverable VAT adjustment on prior year performance fee

155

(66)

7

1,362

1,627

3,474

 

In addition to the management fees disclosed above, North Atlantic Value LLP is also paid an investment management related fee of £125,000 per annum.

Shareholders should also note the payments made under share base remuneration as disclosed in note 7 to these financial statements.

11. financial information

The annual financial information contained in this half yearly report does not constitute full Statutory accounts as defined in Section 434 of the Companies Act 2006. The financial information for the periods ended 31 July 2011 and 31 July 2010 is not a financial year and has not been audited. The statutory accounts for the financial year ended 31 January 2011 have been delivered to the Registrar of Companies. Those accounts received a qualified audit opinion arising from the non consolidation of Hampton Investment Properties Limited. The Audit Report did not include any other reference to any matters to which the Auditors drew attention by way of emphasis without qualifying the Report and did not contain statements under Section 498(2) of the Companies Act 2006.

SHAREHOLDER INFORMATION

financial calendar

Preliminary results MayAnnual Report MayAnnual General Meeting JuneHalf -Yearly figures announced SeptemberHalf -Yearly Report posted September

share price

The Company's mid-market share price is quoted daily in the Financial Times appearing under "Investment Companies".

They also appear on:

Reuters: Convertible Loan Stock NASp.L

Bloomberg: NAS. LN

SEAQ Ordinary Shares: NAS

Trustnet: www.trustnet.ltd.uk

net asset value

The latest net asset value of the Company can be found on the North Atlantic Value LLP website: www.navalue.co.uk

share dealing

Investors wishing to purchase more Ordinary Shares or dispose of all or part of their holding may do so through a stockbroker. Many banks also offer this service.

The Company's registrars are Capita Registrars. In the event of any queries regarding your holding of shares, please contact the registrars on: 0870 458 4577, or by email on ssd@capitaregistrars.com

Changes of name or address must be notified to the registrars in writing at:

Capita Registrars

The Registry

34 Beckenham Road

Beckenham

Kent BR3 4TU

 

The Half Yearly Report will be posted to Shareholders and loan stock holders very shortly. It will also be available on the North Atlantic Value LLP website www.navalue.co.uk or in hard copy format from the Company's Registered Office which is Ground Floor, Ryder Court, 14 Ryder Street, London SW1Y 6QB.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR DMGGLZRZGMZM
Date   Source Headline
17th Apr 202410:52 amRNSNet Asset Value(s)
12th Apr 20243:48 pmRNSHolding(s) in Company
8th Apr 20249:42 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202412:45 pmRNSTransaction in Own Shares - Replacement
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20243:55 pmRNSNet Asset Value(s)
15th Mar 202410:01 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSDirector/PDMR Shareholding
19th Feb 202411:07 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSDividend Declaration
15th Feb 20247:00 amRNSNet Asset Value(s)
8th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20249:14 amRNSNew Investment: Crest Foods
5th Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSDirector/PDMR Shareholding
17th Jan 20243:32 pmRNSNet Asset Value(s)
27th Dec 20237:00 amRNSDirector Declaration
19th Dec 20237:00 amRNSNet Asset Value(s)
6th Dec 20237:41 amRNSInvestment Update: Ten Entertainment Group Plc
16th Nov 202312:44 pmRNSNet Asset Value(s)
30th Oct 20232:30 pmRNSTransaction in Own Shares
23rd Oct 20232:10 pmRNSTransaction in Own Shares
16th Oct 202312:19 pmRNSNet Asset Value(s)
12th Oct 20238:43 amRNSReplacement: Private Equity Investment Disposal
12th Oct 20237:00 amRNSPrivate Equity investment disposal
9th Oct 20233:02 pmRNSTransaction in Own Shares
15th Sep 20237:00 amRNSHalf-year Report
14th Sep 20231:43 pmRNSNet Asset Value(s)
31st Aug 20234:40 pmRNSCompany Secretary Change
29th Aug 20233:46 pmRNSTransaction in Own Shares - Replacement
29th Aug 20232:49 pmRNSTransaction in Own Shares
21st Aug 20233:07 pmRNSTransaction in Own Shares
16th Aug 20234:15 pmRNSTransaction in Own Shares
15th Aug 202310:03 amRNSNet Asset Value(s)
14th Aug 20232:09 pmRNSTransaction in Own Shares
8th Aug 20234:30 pmRNSTransaction in Own Shares
7th Aug 20234:28 pmRNSTransaction in Own Shares
25th Jul 202312:52 pmRNSNanoco Group Plc
18th Jul 20233:23 pmRNSNet Asset Value(s)
17th Jul 202312:41 pmRNSPortfolio Update
10th Jul 20239:39 amRNSTransaction in Own Shares
3rd Jul 202310:14 amRNSTransaction in Own Shares
30th Jun 202312:17 pmRNSDirector/PDMR Shareholding
26th Jun 202310:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSResult of AGM
15th Jun 20231:15 pmRNSNet Asset Value(s)
26th May 20235:10 pmRNSDirectorate Change
22nd May 20231:37 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.